| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Randomized, Open-Label Study Conducted to Evaluate the Bioequivalence of Pegfilgrastim-cbqv On-Body Injector Versus Prefilled Syringe in Healthy Male Participants
|
Tang, Hong
|
|
|
41 |
3 |
p. 991-1009
|
artikel
|
| 2 |
Artificial Intelligence in Liver Diseases: Recent Advances
|
Lu, Feifei
|
|
|
41 |
3 |
p. 967-990
|
artikel
|
| 3 |
Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study
|
Ketkar, Amita
|
|
|
41 |
3 |
p. 1075-1102
|
artikel
|
| 4 |
Autologous Skin Cell Suspension for Full-Thickness Skin Defect Reconstruction: Current Evidence and Health Economic Expectations
|
Kahn, Steven A.
|
|
|
41 |
3 |
p. 891-900
|
artikel
|
| 5 |
Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy
|
Mankan, Arun K.
|
|
|
41 |
3 |
p. 885-890
|
artikel
|
| 6 |
Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal Study
|
AlHarbi, Mohammed
|
|
|
41 |
3 |
p. 1120-1150
|
artikel
|
| 7 |
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
|
Waitzberg, Dan
|
|
|
41 |
3 |
p. 901-914
|
artikel
|
| 8 |
Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1)
|
Langford, Richard
|
|
|
41 |
3 |
p. 1025-1045
|
artikel
|
| 9 |
Comparative Safety of Pulsed Field Ablation and Cryoballoon Ablation Technologies for Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation: A Critical Literature Review and Indirect Treatment Comparison
|
Maccioni, Sonia
|
|
|
41 |
3 |
p. 932-944
|
artikel
|
| 10 |
Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
|
Tangri, Navdeep
|
|
|
41 |
3 |
p. 1151-1167
|
artikel
|
| 11 |
Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials
|
van Dijkman, Sven C.
|
|
|
41 |
3 |
p. 1201-1225
|
artikel
|
| 12 |
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
|
Paller, Amy S.
|
|
|
41 |
3 |
p. 1046-1061
|
artikel
|
| 13 |
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study
|
Yamamoto, Eiichiro
|
|
|
41 |
3 |
p. 1284-1303
|
artikel
|
| 14 |
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study
|
Lehrke, Michael
|
|
|
41 |
3 |
p. 1184-1200
|
artikel
|
| 15 |
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing
|
Kodjikian, Laurent
|
|
|
41 |
3 |
p. 1010-1024
|
artikel
|
| 16 |
Outcomes of Patients with COPD Treated with ICS/LABA Before and After Initiation of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)
|
McCormack, Meredith
|
|
|
41 |
3 |
p. 1245-1261
|
artikel
|
| 17 |
Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension
|
Barberà, Joan
|
|
|
41 |
3 |
p. 1062-1074
|
artikel
|
| 18 |
Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE
|
Muller, Audrey
|
|
|
41 |
3 |
p. 1103-1119
|
artikel
|
| 19 |
Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI)
|
Wu, Haiting
|
|
|
41 |
3 |
p. 1168-1183
|
artikel
|
| 20 |
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study
|
Guttman-Yassky, Emma
|
|
|
41 |
3 |
p. 928-931
|
artikel
|
| 21 |
The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
|
Price, David
|
|
|
41 |
3 |
p. 1262-1283
|
artikel
|
| 22 |
The Cost of Seasonal Influenza: A Systematic Literature Review on the Humanistic and Economic Burden of Influenza in Older (≥ 65 Years Old) Adults
|
Langer, Jakob
|
|
|
41 |
3 |
p. 945-966
|
artikel
|
| 23 |
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast
|
Black, Peter C.
|
|
|
41 |
3 |
p. 915-927
|
artikel
|
| 24 |
Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis
|
Ip, Andrew
|
|
|
41 |
3 |
p. 1226-1244
|
artikel
|
Tijdschrift beschrijving